Mosapride Tablets 5mg â€“ Gastrointestinal Motility Support Therapy

Selective 5-HT4 receptor agonist. Improves gastric motility and digestion. Effective for functional GI disorders. Supports relief from bloating and discomfort. Manufactured under global pharmaceutical standards.

Mosapride Tablets 5mg (CAS No: 113828-51-8) by LARKSOIS Pharma are a specialized gastrointestinal therapy. Act as selective 5-HT4 receptor agonists. Designed to improve gastric emptying and motility. Provide relief from dyspepsia and reflux-related symptoms. Manufactured under strict international standards.

Request Quote

Overview

Mosapride Tablets 5mg support gastrointestinal motility.
Belong to the prokinetic drug class.
Stimulate acetylcholine release in the gut.
Improve upper digestive tract movement.
Ensure effective symptom relief in GI disorders.

Introduction

Mosapride Tablets 5mg (CAS No: 113828-51-8) by LARKSOIS Pharma are a specialized gastrointestinal therapy.
Act as selective 5-HT4 receptor agonists.
Designed to improve gastric emptying and motility.
Provide relief from dyspepsia and reflux-related symptoms.
Manufactured under strict international standards.

Important Information

Prokinetic agent for GI motility.
Not an NSAID or painkiller.
Acts on serotonin receptors in the gut.
Supports digestive movement and function.
Requires medical supervision for appropriate use.

Dosage

General

Adults: 5mg three times daily
Dose as per physician advice
Adjust based on patient condition

Administration

Take before or after meals
Swallow with water
Maintain consistent dosing schedule
Do not exceed prescribed dosage

Important

Use under medical supervision
Monitor response in long-term use
Adjust in renal or hepatic impairment

Storage

Store in a cool, dry place
Protect from moisture, heat, and light
Keep in original packaging
Keep out of reach of children

Shelf Life

Shelf life as per approved labeling
Check expiry before use
Use only within expiry date

Manufacturing

Controlled API and excipient sourcing
Precision tablet compression
In-process quality checks
Finished product testing for assay and dissolution
Compliance with international pharmaceutical standards

Precautions

Avoid in hypersensitivity to mosapride
Contraindicated in GI obstruction or perforation
Use cautiously in elderly patients
Monitor in renal or hepatic impairment
Use under medical supervision

Side Effects

Diarrhea
Abdominal pain
Dizziness
Constipation
Headache
Insomnia
Nausea

Expert View

Effective GI motility agent.
Supports digestive function improvement.
Widely used in dyspepsia management.
Valuable adjunct in reflux therapy.
Reliable and consistent performance.

Indications

Functional dyspepsia
Postprandial fullness
Early satiety
Bloating
Upper abdominal discomfort
Reflux-related symptoms
Delayed gastric emptying

Maintenance

Use based on symptom response
Long-term use under medical supervision
Adjust dose as needed
Monitor GI function
Review therapy periodically

Why Choose

Targeted GI motility mechanism
Selective 5-HT4 receptor action
Established international usage
Useful for digestive discomfort
Export-ready pharmaceutical quality

Frequently Asked Questions

Common product and supply questions.

What is mosapride used for?+

Mosapride Tablets are used to improve gastrointestinal motility and relieve symptoms such as bloating, fullness, and upper abdominal discomfort in functional digestive disorders.

Why is mosapride not FDA approved?+

Mosapride is marketed in several countries but is not approved by the US FDA, which is why it is not available as a prescription medicine in the United States.

Can I take mosapride after a meal?+

Yes, mosapride can be taken before or after meals depending on medical advice and approved product labeling.

What is pantoprazole with mosapride?+

It is a combination approach where pantoprazole reduces acid and mosapride improves gastrointestinal motility, sometimes used in reflux or dyspepsia management.

Is mosapride safe for kidneys?+

Mosapride should be used cautiously in patients with kidney issues and only under medical supervision.